Genomma Lab Internacional SAB 

$0.8368
40
-$0.11-11.92% Monday 20:00

Statistics

Day High
0.95
Day Low
0.95
52W High
1.17
52W Low
0.8368
Volume
5,000
Avg. Volume
258
Mkt Cap
836.8M
P/E Ratio
10.56
Dividend Yield
5.46%
Dividend
0.05

Upcoming

Dividends

5.46%Dividend Yield
Jun 26
$0.01
Mar 26
$0.01
Dec 25
$0.01
Sep 25
$0.01
Jul 25
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
10.17%
1Y Growth
6.25%

Earnings

22JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.02
0.03
0.03
0.04
Expected EPS
0.0308502
Actual EPS
N/A

Financials

9.15%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
930.23MRevenue
85.11MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNMLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson operates in the pharmaceuticals and consumer health sectors, directly competing with Genomma Lab's range of over-the-counter and personal care products.
Procter & Gamble
PG
Mkt Cap352.57B
Procter & Gamble offers a wide range of consumer health and personal care products, competing in similar markets as Genomma Lab.
Bayer
BAYRY
Mkt Cap59.69B
Bayer AG's consumer health division produces over-the-counter drugs and nutritional supplements, competing with Genomma Lab's product portfolio.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline, with its consumer healthcare division, competes in the over-the-counter medication market, similar to Genomma Lab.
Pfizer
PFE
Mkt Cap138.61B
Pfizer has a consumer healthcare division that produces over-the-counter medications, directly competing with Genomma Lab's offerings.
Novartis
NVS
Mkt Cap305.1B
Novartis operates in the pharmaceuticals sector, including over-the-counter drugs, competing with Genomma Lab's range of products.
Sanofi
SNY
Mkt Cap103.32B
Sanofi offers a broad portfolio of over-the-counter products, competing in the same space as Genomma Lab.
Merck
MRK
Mkt Cap319.99B
Merck, through its various healthcare products, competes in the pharmaceutical and consumer health markets, overlapping with Genomma Lab's market.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie, with its focus on pharmaceuticals, has a range of products that compete in the healthcare sector alongside Genomma Lab.
Church & Dwight
CHD
Mkt Cap23.36B
Church & Dwight offers a variety of household and personal care products, competing in the consumer goods sector alongside Genomma Lab.

About

Genomma Lab Internacional, S.A.B. de C.V., alongside its various operating units, specializes in the creation, promotion, and distribution of a wide array of over-the-counter (OTC) pharmaceutical goods and personal care items. Its operations span across Mexico and numerous international markets. The company's extensive product portfolio addresses diverse consumer needs, encompassing categories such as skincare, hair care, general health and wellness solutions, and pain management. Specific offerings include remedies for coughs and colds, digestive health aids, sexual well-being products, antiperspirants and deodorants, hand sanitizers, isotonic beverages, and shaving essentials. Beyond these, it also markets specialized pharmaceuticals such as analgesics, antifungals, and treatments for hemorrhoids. These products are brought to market under a multitude of well-known brands, including Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, among others. Established in 1996, Genomma Lab Internacional, S.A.B. de C.V. maintains its corporate headquarters in Mexico City, Mexico.
Show more...
CEO
Lic. Rodrigo Alonso Herrera Aspra
Employees
1605
Country
Mexico
ISIN
MX01LA010006

Listings

0 Comments

Share your thoughts

FAQ

What is Genomma Lab Internacional SAB stock price today?
The current price of GNMLF is $0.84 USD — it has decreased by -11.92% in the past 24 hours. Watch Genomma Lab Internacional SAB stock price performance more closely on the chart.
What is Genomma Lab Internacional SAB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genomma Lab Internacional SAB stocks are traded under the ticker GNMLF.
Is Genomma Lab Internacional SAB stock price growing?
GNMLF stock has fallen by -11.92% compared to the previous week, the month change is a -22.52% fall, over the last year Genomma Lab Internacional SAB has showed a -25.29% decrease.
What is Genomma Lab Internacional SAB market cap?
Today Genomma Lab Internacional SAB has the market capitalization of 836.8M
When is the next Genomma Lab Internacional SAB earnings date?
Genomma Lab Internacional SAB is going to release the next earnings report on July 22, 2026.
What were Genomma Lab Internacional SAB earnings last quarter?
GNMLF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.03 USD resulting in a +6.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genomma Lab Internacional SAB revenue for the last year?
Genomma Lab Internacional SAB revenue for the last year amounts to 930.23M USD.
What is Genomma Lab Internacional SAB net income for the last year?
GNMLF net income for the last year is 85.11M USD.
Does Genomma Lab Internacional SAB pay dividends?
Yes, GNMLF dividends are paid quarterly. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 5.46%.
How many employees does Genomma Lab Internacional SAB have?
As of July 10, 2026, the company has 1,605 employees.
In which sector is Genomma Lab Internacional SAB located?
Genomma Lab Internacional SAB operates in the Health & Wellness sector.
When did Genomma Lab Internacional SAB complete a stock split?
The last stock split for Genomma Lab Internacional SAB was on August 03, 2010 with a ratio of 2:1.
Where is Genomma Lab Internacional SAB headquartered?
Genomma Lab Internacional SAB is headquartered in Mexico City, Mexico.